Anaphylaxis: assessment and referral after emergency treatment (CG134)Product type:GuidanceProgramme:Clinical guidelineLast updated: 24 August 2020Published: 14 December 2011
Lanadelumab for preventing recurrent attacks of hereditary angioedema (TA606)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 16 October 2019
Intranasal phototherapy for allergic rhinitis (IPG616)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 13 June 2018
ImmunoCAP ISAC 112 for multiplex allergen testing (DG24)Product type:GuidanceProgramme:Diagnostics guidancePublished: 18 May 2016
Drug allergy: diagnosis and management (CG183)Product type:GuidanceProgramme:Clinical guidelinePublished: 3 September 2014
Omalizumab for treating severe persistent allergic asthma (TA278)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 April 2013
Pharmalgen for the treatment of bee and wasp venom allergy (TA246)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 February 2012
Food allergy in under 19s: assessment and diagnosis (CG116)Product type:GuidanceProgramme:Clinical guidelinePublished: 23 February 2011